213 related articles for article (PubMed ID: 15181415)
21. [Activated proteine C].
Montravers P; Quintard H; Piednoir P
Ann Fr Anesth Reanim; 2006 Mar; 25(3):270-4. PubMed ID: 16387470
[TBL] [Abstract][Full Text] [Related]
22. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP
Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
[TBL] [Abstract][Full Text] [Related]
23. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
[TBL] [Abstract][Full Text] [Related]
24. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of recombinant human activated protein C in a ewe model of septic shock.
Wang Z; Su F; Rogiers P; Vincent JL
Crit Care Med; 2007 Nov; 35(11):2594-600. PubMed ID: 17901839
[TBL] [Abstract][Full Text] [Related]
26. Antithrombin replacement in patients with sepsis and septic shock.
Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
[TBL] [Abstract][Full Text] [Related]
27. Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis.
Chawla LS; Seneff MG; Nelson DR; Williams M; Levy H; Kimmel PL; Macias WL
Clin J Am Soc Nephrol; 2007 Jan; 2(1):22-30. PubMed ID: 17699383
[TBL] [Abstract][Full Text] [Related]
28. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
29. The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
Jochberger S; Dörler J; Luckner G; Mayr VD; Wenzel V; Ulmer H; Morgenthaler NG; Hasibeder WR; Dünser MW
Crit Care Med; 2009 Feb; 37(2):476-82. PubMed ID: 19114902
[TBL] [Abstract][Full Text] [Related]
30. Plasma antioxidant status in septic critically ill patients: a decrease over time.
Doise JM; Aho LS; Quenot JP; Guilland JC; Zeller M; Vergely C; Aube H; Blettery B; Rochette L
Fundam Clin Pharmacol; 2008 Apr; 22(2):203-9. PubMed ID: 18353115
[TBL] [Abstract][Full Text] [Related]
31. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
Janković B; Pasić S; Marković M; Veljković D; Milicić M
Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
[TBL] [Abstract][Full Text] [Related]
32. Protein C concentrations correlate with organ dysfunction and predict outcome independent of the presence of sepsis.
Brunkhorst F; Sakr Y; Hagel S; Reinhart K
Anesthesiology; 2007 Jul; 107(1):15-23. PubMed ID: 17585211
[TBL] [Abstract][Full Text] [Related]
33. Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer.
Malato A; Saccullo G; Coco LL; Caracciolo C; Raso S; Santoro M; Zammit V; Siragusa S
Am J Hematol; 2012 Feb; 87(2):230-2. PubMed ID: 22228308
[TBL] [Abstract][Full Text] [Related]
34. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
du Cheyron D; Bouchet B; Bruel C; Daubin C; Ramakers M; Charbonneau P
Crit Care; 2006; 10(2):R45. PubMed ID: 16542495
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of severe sepsis in intensive care units in the Slovak Republic.
Záhorec R; Firment J; Straková J; Mikula J; Malík P; Novák I; Zeman J; Chlebo P
Infection; 2005 Jun; 33(3):122-8. PubMed ID: 15940412
[TBL] [Abstract][Full Text] [Related]
36. Platelet aggregation and blood rheology in severe sepsis/septic shock: relation to the Sepsis-related Organ Failure Assessment (SOFA) score.
Alt E; Amann-Vesti BR; Madl C; Funk G; Koppensteiner R
Clin Hemorheol Microcirc; 2004; 30(2):107-15. PubMed ID: 15004335
[TBL] [Abstract][Full Text] [Related]
37. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability.
Waeschle RM; Moerer O; Hilgers R; Herrmann P; Neumann P; Quintel M
Crit Care; 2008; 12(5):R129. PubMed ID: 18939991
[TBL] [Abstract][Full Text] [Related]
38. Successful protein C concentrate administration during initiation of oral anticoagulation in adult patients with severe congenital protein C deficiency: report of two cases.
Imberti D; Pierfranceschi MG
Pathophysiol Haemost Thromb; 2008; 36(2):53-7. PubMed ID: 19127082
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock.
Varpula M; Pulkki K; Karlsson S; Ruokonen E; Pettilä V;
Crit Care Med; 2007 May; 35(5):1277-83. PubMed ID: 17414731
[TBL] [Abstract][Full Text] [Related]
40. Protein C zymogen in adults with severe sepsis or septic shock.
Crivellari M; Silvetti S; Gerli C; Landoni G; Franco A; Bove T; Pappalardo F; Zangrillo A
Med Intensiva; 2014; 38(5):278-82. PubMed ID: 23876943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
